Thrombophilia and Adverse Pregnancy Outcome

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 2006 English Publisher:Elsevier BVJournal:Obstetrics and Gynecology Clinics of North America, volume 33, pages 443-456 (issn: 0889-8545,

Copyright policy )

Authors: Benjamin, Brenner;

doi: 10.1016/j.ogc.2006.05.010

pmid: 16962920

Thrombophilia and Adverse Pregnancy Outcome

- Summary
- Subjects
- Metrics

Abstract

This article focuses on the clinical evaluation and management of women who have thrombophilia-related placental vascular complications, including fetal loss, pre-eclampsia, intrauterine fetal growth restriction, and placental abruption. All are major causes of maternal and fetal adverse outcomes.

Related Organizations

Rambam Health Care Campus
Israel

Keywords

Hemostasis, Fetal Growth Retardation, Pregnancy Complications, Hematologic, Hyperhomocysteinemia, Pregnancy Outcome, Abortion, Spontaneous, Fibrinolytic Agents, Pre-Eclampsia, Pregnancy, Mutation, Humans, Thrombophilia, Female, Abruptio Placentae, Methylenetetrahydrofolate Reductase (NADPH2)

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	27
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%